Sector Focus

Biotechnology

Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.

Clients

Centocor, Inc. (Now Janssen Biotech)

Centocor is a leader in the field of biomedicines. They seek innovative ways to treat cancer and immune-mediated inflammatory disorders, such as rheumatoid arthritis and plaque psoriasis. Centocor is now Janssen Biotech.

Search Projects

  • Director, Immunology